Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P2Y2 receptor agonist for tear film stability in orthokeratology users
ChiCTR2300077893Phase 4Recruiting
- Sponsor
- Shanghai Bright Eye Hospital
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of diquafosol in myopia (2 arms), sponsored by Shanghai Bright Eye Hospital. Primary endpoint: Tear film breakup time. Started Nov 2023; status: recruiting.
02
Drugs
diquafosol
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2300077893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077893.